24/7 Patient Assistance: 760-405-8205

Chris Rhoades , MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Chris Rhoades is a medical oncologist from Lima,Ohio and he works at several hospitals in the area, such as Lima Memorial Health System and St. Rita's Medical Center. He did his Medical Schooling from The Ohio State University College of Medicine and Residency in Internal Medicine from Ohio State University Hospital. The doctor is certified in Medical Oncology from American Board of Internal Medicine and has an experience of more than 20 years.

    Insurance Accepted

    Aetna Choice POS IIAetna HMO

  • Education & Training


    The Ohio State University College of Medicine

    Medical School


    Ohio State University Hospital



    Ohio State University Hospital


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Lima Memorial Health System

    Languages: English/Spanish

    +1 419-228-3335

    1001 Bellefontaine Ave

    Lima, OH 45804

    Read More
  • Publications & Memberships

    Dr. Chris Rhoades has contributed to 3 publications.

    Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.

    Schuller, D.E., Ozer, E., Agrawal, A., Grecula, J.C., Rhoades, C.A., Young, D.C.; Arch Otolaryngol Head Neck Surg. 2007 Apr.

    See more >>

    Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients.

    Monk JP, Phillips G, Waite R, Kuhn J, Schaaf LJ, Otterson GA, Guttridge D, Rhoades C, Shah M, Criswell T, Caligiuri MA, Villalona-Calero MA; J. Clin. Oncol.. 2006-04-20.

    See more >>

    Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.

    Mrozek, E., Ramaswamy, B., Young, D., Rhoades, C.A., Kendra, K., Allen, J., Moore, T., Hauger, M., Watson, H., Merriman, N., Nadella, P., Villalona-Calero, M., Shapiro...; Clin Breast Cancer. 2006 Jun.

    See more >>